Genprex Granted Chinese Patent for REQORSA® Immunogene Therapy in Combination with PD-1 Antibodies to Treat Cancers

Provides Additional Protection in Large Markets for Therapeutic Combination in Acclaim-2 Phase 1/2 Clinical Trial Patent Already Granted for Same Combination in U.S. Japan, Australia, Russia and Mexico AUSTIN, Texas, July 5, 2023 /PRNewswire/ — Genprex, Inc. (“Genprex” or the “Company”)…